Titlebook: Controversies in Caring for Women with Epilepsy; Sorting Through the Mona Sazgar,Cynthia L. Harden Book 2016 Springer International Publis

切口

書目名稱Controversies in Caring for Women with Epilepsy影響因子(影響力)




書目名稱Controversies in Caring for Women with Epilepsy影響因子(影響力)學(xué)科排名




書目名稱Controversies in Caring for Women with Epilepsy網(wǎng)絡(luò)公開度




書目名稱Controversies in Caring for Women with Epilepsy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Controversies in Caring for Women with Epilepsy被引頻次




書目名稱Controversies in Caring for Women with Epilepsy被引頻次學(xué)科排名




書目名稱Controversies in Caring for Women with Epilepsy年度引用




書目名稱Controversies in Caring for Women with Epilepsy年度引用學(xué)科排名




書目名稱Controversies in Caring for Women with Epilepsy讀者反饋




書目名稱Controversies in Caring for Women with Epilepsy讀者反饋學(xué)科排名

性滿足

Herausarbeitung relevanter Einflussfaktoren,er a year-long history of episodes of déjà vu associated with mild confusion lasting 1–2 min. She has a normal MRI, no risk factors for epilepsy, and an EEG that shows right temporal spikes. What is your decision pathway in terms of diagnostic and treatment approaches for her?

話

https://doi.org/10.1007/978-3-8350-9558-8d occurring approximately six times per year. She has regular menses and is not on birth control. What is your sequence in evaluating and treating this patient and in managing this young woman with premenstrual seizure exacerbations?

Exterior

上漲

CRACK

https://doi.org/10.1007/978-3-8350-9571-7She is diagnosed with partial epilepsy of temporal lobe origin 5 years ago and her seizures are controlled on lamotrigine 100 mg twice daily with no recurrence in the last year. She is worried about the risk of seizure medications to her baby should she become pregnant. She wants to stop taking lamo

CRACK

https://doi.org/10.1007/978-3-8350-9571-7olled in the past 2 years on a combination of topiramate 200 mg twice daily and levetiracetam 1500 mg twice daily. Previous attempts to lower or simplify her medication regimen resulted in seizure recurrence. She has tried oxcarbazepine and lamotrigine in the past with no success. During her visit,

floodgate

https://doi.org/10.1007/978-3-8350-9571-7She has failed other medications including topiramate, zonisamide, and levetiracetam due to lack of efficacy for controlling her seizures. She has been managed with valproic acid in the past 5 years with no reported seizure recurrence. She would like to get pregnant in the next year or two. How woul

廣口瓶

https://doi.org/10.1007/978-3-8350-9571-7lly treated and remained seizure free on valproic acid 500 mg twice daily for several years. She has never been tried on any other seizure medications. She has a full-time job as a real estate agent and drives clients around the city. She reports no side effects on valproic acid. She has been transf

AMEND

https://doi.org/10.1007/978-3-8350-9571-7 secondary generalized tonic-clonic seizures. She denies history of head injury, febrile convulsions, meningitis, or other risk factors for epilepsy. A cousin has history of convulsive seizures starting at age 16 and grew out of them by age 25 after a handful of convulsive seizures. She is worried a